Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovica Pepe

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 27, 2024
Negative biopsy histology in men with PI-RADS score 5: is it useful PSMA PET/CT evaluation?Pietro Pepe, Ludovica Pepe, Michele Pennisi
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 15, 2025
PSMA PET/CT in the diagnosis of prostate cancer: why and when?Pietro Pepe, Ludovica Pepe, Daniele Cignoli, et al.
In Vivo (Athens, Greece)|December 29, 2019
Multiparametric MRI <i>Versus</i> SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active SurveillancePietro Pepe, Giuseppe Dibenedetto, Ludovica Pepe, et al.
Anticancer Research|June 4, 2021
Prostate Cancer Diagnosis and Management During One Year of the COVID-19 PandemicPietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 30, 2020
Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsyPietro Pepe, Ludovica Pepe, Paolo Panella, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 15, 2026
Digital pathology for repeat prostate biopsy reassessment during active surveillance: an institutional experienceLudovica Pepe, Mara Curduman, Pietro Pepe, et al.
Urology Case Reports|October 26, 2020
Giant retrovesical ectopic prostatic adenoma. Case report and revision of the literaturePietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
In Vivo (Athens, Greece)|April 30, 2024
Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active SurveillancePietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Clinical Genitourinary Cancer|March 1, 2021
Which Prostate Biopsy in Men Enrolled in Active Surveillance? Experience in 110 Men Submitted to Scheduled Three-Years Transperineal Saturation Biopsy Combined With Fusion Targeted CoresPietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|September 27, 2022
Confirmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassification rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsyPietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 27, 2024
Negative biopsy histology in men with PI-RADS score 5: is it useful PSMA PET/CT evaluation?Pietro Pepe, Ludovica Pepe, Michele Pennisi
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 15, 2025
PSMA PET/CT in the diagnosis of prostate cancer: why and when?Pietro Pepe, Ludovica Pepe, Daniele Cignoli, et al.
In Vivo (Athens, Greece)|December 29, 2019
Multiparametric MRI <i>Versus</i> SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active SurveillancePietro Pepe, Giuseppe Dibenedetto, Ludovica Pepe, et al.
Anticancer Research|June 4, 2021
Prostate Cancer Diagnosis and Management During One Year of the COVID-19 PandemicPietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 30, 2020
Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsyPietro Pepe, Ludovica Pepe, Paolo Panella, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 15, 2026
Digital pathology for repeat prostate biopsy reassessment during active surveillance: an institutional experienceLudovica Pepe, Mara Curduman, Pietro Pepe, et al.
Urology Case Reports|October 26, 2020
Giant retrovesical ectopic prostatic adenoma. Case report and revision of the literaturePietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
In Vivo (Athens, Greece)|April 30, 2024
Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active SurveillancePietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Clinical Genitourinary Cancer|March 1, 2021
Which Prostate Biopsy in Men Enrolled in Active Surveillance? Experience in 110 Men Submitted to Scheduled Three-Years Transperineal Saturation Biopsy Combined With Fusion Targeted CoresPietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|September 27, 2022
Confirmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassification rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsyPietro Pepe, Ludovica Pepe, Michele Pennisi, et al.
Pageof 6